|
KPHMW Kiora Pharmaceuticals 1372514 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-2,417,984.00 |
| Balance Sheet |
|
Current Assets
|
$18,682,848.00 |
|
Assets
|
$21,227,089.00 |
|
Current Liabilities
|
$2,798,264.00 |
|
Liabilities
|
$7,292,528.00 |
|
Equity
|
$13,934,561.00 |
|
Shares Out
|
3993469.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,161,332.00 |
|
Investing Cash Flow
|
$5,400,982.00 |
| Market Analysis |
Market Cap
|
$79,869.38 |
|
Price
|
$0.02 |
|
BVPS
|
3.49 |
|
PB
|
0.01 |
|
EPS
|
-0.58 |
|
FCF
|
$-3,166,350.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:32:03 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:02:09 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view KPHMW documents filed with the SEC.
KPHMW Filings
Clear
